Faculty Collaboration Database

1. Stetler-Stevenson WG, Kreck ML, Talano JA. Assaying Type IV Collagenase Activity Using [3H] Pepsinized Human Placental Type IV Collagen. DuPont Biotech Update. 1990 Jun;15(3)54-55

2. Stetler-Stevenson WG, Talano JA, Gallagher ME, Krutzsch HC, Liotta LA. Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. Am J Med Sci. 1991 Sep;302(3):163-70.

3. Talano JA. Development of a Fluorogenic Assay for Type IV Collagenase and the Characterization of Inhibition by Tissue Inhibitor Metalloproteinase-2 (Timp-2). Senior Thesis, Department of Biology, Georgetown University, 1991. Presented, National Cancer Institute, Section of Tumor Invasion and Metastases, May, 1991. Presented, Georgetown University, Department of Biology, May, 1991.

4. Talano JA, Katz BZ. Long-term follow-up of children with fever of unknown origin. Clin Pediatr (Phila). 2000 Dec;39(12):715-7.

5. Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics. 2003 Jun;111(6 Pt 1):e661-5.

6. Talano JM, Casper JT, Camitta BM, Keever-Taylor CA, Murray KJ, Eapen M, Pierce KL, Margolis DA. Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. Bone Marrow Transplant. 2006 Jan;37(2):135-41.

7. Talano JA, Margolis DA. Recent molecular and cellular advances in pediatric bone marrow transplantation. Pediatr Clin North Am. 2006 Aug;53(4):685-98.

8. Conlon JD, Dauenhauer M, Tonkovic-Capin V, Talano J, Margolis D, Drolet BA, Fairley JA. Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients. J Am Acad Dermatol. 2008 Mar;58(3):484-7.

9. Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys. 2008 Apr 01;70(5):1546-51. PMCID: PMC2386758

10. Zidan H, Lo S, Wiebe D, Talano J, Alemzadeh R. Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver. Pediatr Blood Cancer. 2008 Jun;50(6):1280-1.

11. Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N. Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. Biol Blood Marrow Transplant. 2009 Dec;15(12):1609-19. PMCID: PMC2783272

12. Anderson L, Gregg D, Margolis D, Casper J, Talano J. Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series. Bone Marrow Transplant. 2010 Aug;45(8):1357-9.

13. de Montalembert M, Dumont MD, Heilbronner C, Brousse V, Charrara O, Pellegrino B, Piguet C, Soussan V, Noizat-Pirenne F. Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica. 2011 Jun;96(6):801-7. PMCID: PMC3105640

14. Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, Broadwater G, Monroy R, Kurtzberg J. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant. 2011 Apr;17(4):534-41.

15. Biank VF, Sheth MK, Talano J, Margolis D, Simpson P, Kugathasan S, Stephens M. Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis. J Pediatr. 2011 Nov;159(5):808-12. PMCID: PMC3191286

16. Rangarajan HG, Grochowski D, Mulberry MF, Gheorghe G, Camitta BM, Talano JA. Treatment of recurrent CNS disease post-bone marrow transplant in familial HLH. Pediatr Blood Cancer. 2012 Jul 15;59(1):189-90.

17. Freed J, Talano J, Small T, Ricci A, Cairo MS. Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'. Bone Marrow Transplant. 2012 Dec;47(12):1489-98.

18. Bacher U, Talano JA, Bishop MR. Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies. Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S62-73.

19. Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW, Herschberger A, Hill KS, Moffet JR, Morrison RR, Norris AL, Petrovic A, Spear DA, Steiner ME, Talano JA, Tamburro RF, Wagner J, McArthur J, Pediatric Acute Lung Injury and Sepsis (PALISI) Network. Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant. Pediatr Crit Care Med. 2013 Mar;14(3):261-7.

20. Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE, EBV-HLH Rituximab Study Group. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. 2013 Aug;162(3):376-82. PMCID: PMC3776423

21. Rangarajan HG, Punzalan RC, Camitta BM, Talano JA. The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients. Br J Haematol. 2013 Nov;163(3):357-64.

22. Kurtzberg J, Prockop S, Teira P, Bittencourt H, Lewis V, Chan KW, Horn B, Yu L, Talano JA, Nemecek E, Mills CR, Chaudhury S. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.Biol Blood Marrow Transplant. 2014 Feb;20(2):229-35. doi: 10.1016/j.bbmt.2013.11.001. Epub 2013 Nov 8.

23. Talano JM, Pulsipher MA, Symons HJ, Militano O, Shereck EB, Giller RH, Hancock L, Morris E, Cairo MS. New frontiers in pediatric Allo-SCT. Bone Marrow Transplant. 2014 Sep;49(9):1139-45. PMCID: PMC4439009

24. Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano JA, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S, Thakar MS, Baker KS, Rawlings DJ, Englund JA, Flowers ME, Deeg HJ, Storb R, Woolfrey AE. Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. Biol Blood Marrow Transplant. 2014 Dec;20(12):1996-2003. PMCID: PMC4324724

25. Talano JA, Cairo MS. Smoothing the crescent curve: sickle cell disease. Hematology Am Soc Hematol Educ Program. 2014 Dec 05;2014(1):468-74.

26. Satwani P, Jin Z, Martin PL, Bhatia M, Garvin JH, George D, Chaudhury S, Talano J, Morris E, Harrison L, Sosna J, Peterson M, Militano O, Foley S, Kurtzberg J, Cairo MS. Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. Leukemia. 2015 Feb;29(2):448-55.

27. Talano JA, Cairo MS. Hematopoietic stem cell transplantation for sickle cell disease: state of the science. Eur J Haematol. 2015 May;94(5):391-9.

28. Oshrine B, Talano JA. Curative treatment for severe sickle cell disease: allogeneic transplantation. Clin Adv Hematol Oncol. 2015 Apr;13(4):249-56.

29. Burke MJ, Verneris MR, Le Rademacher J, He W, Abdel-Azim H, Abraham AA, Auletta JJ, Ayas M, Brown VI, Cairo MS, Chan KW, Diaz Perez MA, Dvorak CC, Egeler RM, Eldjerou L, Frangoul H, Guilcher GMT, Hayashi RJ, Ibrahim A, Kasow KA, Leung WH, Olsson RF, Pulsipher MA, Shah N, Shah NN, Thiel E, Talano JA, Kitko CL. Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015 Dec;21(12):2154-2159. PMCID: PMC4654112

30. Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins AM, Gibson B, Sedlacek P, Krol L, Strahm B, Zaidman I, Kalwak K, Talano JA, Woolfrey A, Fraser C, Meyts I, Müller I, Wachowiak J, Bernardo ME, Veys P, Sykora KW, Gennery AR, Slatter M. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. Blood. 2016 Jul 21;128(3):440-8. PMCID: PMC4957165

31. Bock AM, LeVeque M, Camitta B, Talano JA. Successful treatment of recurrent CNS disease post-bone marrow transplant in children with familial hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2016 Dec;63(12):2154-2158.

32. Marsh RA, Jordan MB, Talano JA, Nichols KE, Kumar A, Naqvi A, Vaiselbuh SR, Histiocyte Society Salvage Therapy Working Group. Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience. Pediatr Blood Cancer. 2017 Apr;64(4).

33. Erker C, Harker-Murray P, Talano JA. Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. Pediatr Clin North Am. 2017 Feb;64(1):91-109.

34. Burroughs LM, Shimamura A, Talano JA, Domm JA, Baker KK, Delaney C, Frangoul H, Margolis DA, Baker KS, Nemecek ER, Geddis AE, Sandmaier BM, Deeg HJ, Storb R, Woolfrey AE. Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders. Biol Blood Marrow Transplant. 2017 Oct;23(10):1669-1677. PMCID: PMC5605451

35. Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D, Talano J. Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis. Blood Adv. 2017 Aug 22;1(19):1533-1536. PMCID: PMC5728466

36. Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano JA, Pulsipher MA, Baker KS. Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018 Oct;53(10):1278-1287. PMCID: PMC6158112

37. Connelly JA, Marsh R, Parikh S, Talano JA. Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art. J Pediatric Infect Dis Soc. 2018 May 09;7(suppl_1):S31-S39. PMCID: PMC5946867

38. Nemecek ER, Hilger RA, Adams A, Shaw BE, Kiefer D, Le-Rademacher J, Levine JE, Yanik G, Leung W, Talano JA, Haut P, Delgado D, Kapoor N, Petrovic A, Adams R, Hanna R, Rangarajan H, Dalal J, Chewning J, Verneris MR, Epstein S, Burroughs L, Perez-Albuerne ED, Pulsipher MA, Delaney C. Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium. Biol Blood Marrow Transplant. 2018 Aug;24(8):1651-1656. PMCID: PMC6108922

39. Hochberg J, Zahler S, Geyer MB, Chen N, Krajewski J, Harrison L, Militano O, Ozkaynak MF, Cheerva AC, Talano J, Moore TB, Gillio AP, Walters MC, Baxter-Lowe LA, Hamby C, Cairo MS. The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia. Bone Marrow Transplant. 2019 Feb;54(2):226-235.

40. Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JM, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA. Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. Biol Blood Marrow Transplant. 2018 Oct;24(10):2040-2046. PMCID: PMC6239928

41. Allen CE, Marsh R, Dawson P, Bollard CM, Shenoy S, Roehrs P, Hanna R, Burroughs L, Kean L, Talano JA, Schultz KR, Pai SY, Baker KS, Andolina JR, Stenger EO, Connelly J, Ramirez A, Bryant C, Eapen M, Pulsipher MA. Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies. Blood. 2018 Sep 27;132(13):1438-1451. PMCID: PMC6161764

42. Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, Salit RB, Syrjala KL, Talano JM, Shaw BE. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Cancer. 2019 Jan 01;125(1):144-152. PMCID: PMC6310211

43. Broglie L, Phelan R, Talano JA. First report that prior ECMO therapy does not preclude hematopoietic cell transplantation. Pediatr Hematol Oncol. 2018 May;35(4):245-249.

44. Broglie L, Vitola B, Thakar MS, Basel D, Szabo S, Agni R, Talano JA. Hemophagocytic lymphohistiocytosis mimicking neonatal hemochromatosis. Pediatr Hematol Oncol. 2019 Oct;36(7):451-456. PMCID: PMC10099790

45. Thakar MS, Talano JAM, Tower RL, Kelly ME, Burke MJ. Indications for transplantation in childhood acute leukemia and the impact of minimal residual disease on relapse: A review Clinical Practice. January 2014;11(1):79-90.

46. Bhatt NS, Oshrine B, An Talano J. Hemophagocytic lymphohistiocytosis in adults. Leuk Lymphoma. 2019 Jan;60(1):19-28.

47. McArthur JA, Bambach B, Duncan C, Talano JA, Tamburro RT. Critical Illness Involving Children Undergoing Hematopoietic Progenitor Cell Transplantation Pediatric Critical Care. 2011:1177-1190.

48. Talano JAM, Casper JT, Margolis DA. Hematopoietic Cell Transplantation for Childhood Acute Myeloid Leukemia Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition. 5 March 2009:775-790.

49. Cairo MS, Talano JA, Moore TB, Shi Q, Weinberg RS, Grossman B, Shenoy S. Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial. JAMA Pediatr. 2020 Feb 01;174(2):195-197. PMCID: PMC6902105

50. Seif AE, Li Y, Monos DS, Heidemann SC, Aplenc R, Barrett DM, Casper JT, Freedman JL, Grupp SA, Margolis DA, Olson TS, Teachey DT, Keever-Taylor CA, Wang Y, Talano JM, Bunin NJ. Partially CD3⁺-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic Malignancy. Biol Blood Marrow Transplant. 2020 Mar;26(3):493-501.

51. Levine JE, Antin JH, Allen CE, Burroughs LM, Cooke KR, Devine S, Heslop H, Nakamura R, Talano JA, Yanik G, DiFronzo N. Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant. 2020 May;26(5):e94-e100. PMCID: PMC8062984

52. Blincoe A, Heeg M, Campbell PK, Hines M, Khojah A, Klein-Gitelman M, Talano JA, Speckmann C, Touzot F, Lankester A, Legger GE, Rivière JG, Garcia-Prat M, Alonso L, Putti MC, Lehmberg K, Maier S, El Chazli Y, Elmaksoud MA, Astigarraga I, Kurjane N, Bulina I, Kenina V, Bryceson Y, Rascon J, Lortie A, Goldstein G, Booth C, Worth A, Wassmer E, Schmitt EG, Warren JT, Bednarski JJ, Ali S, Chiang KY, Krueger J, Henry MM, Holland SM, Marsh RA, Ehl S, Haddad E. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis. J Clin Immunol. 2020 Aug;40(6):901-916.

53. Moskop A, Pommert L, Thakrar P, Talano J, Phelan R. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia. Pediatr Blood Cancer. 2021 Jan;68(1):e28739.

54. Friedman D, Dozor AJ, Milner J, D'Souza M, Talano JA, Moore TB, Shenoy S, Shi Q, Walters MC, Vichinsky E, Parsons SK, Braniecki S, Moorthy CR, Ayello J, Flower A, Morris E, Mahanti H, Fabricatore S, Klejmont L, van de Ven C, Baxter-Lowe LA, Cairo MS. Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation. Bone Marrow Transplant. 2021 Sep;56(9):2221-2230. PMCID: PMC8416746

55. Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2021 Aug;27(8):642-649.

56. Rossoff J, Baggott C, Prabhu S, Pacenta H, Phillips CL, Stefanski H, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras N, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Kunicki M, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia. Blood. 2021 Nov 25;138(21):2138-2142. PMCID: PMC8617436

57. Fabrizio VA, Phillips CL, Lane A, Baggott C, Prabhu S, Egeler E, Mavroukakis S, Pacenta H, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Chinnabhandar V, Kunicki M, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report. Blood Adv. 2022 Jan 25;6(2):600-610. PMCID: PMC8791593

58. Fabrizio VA, Boelens JJ, Mauguen A, Baggott C, Prabhu S, Egeler E, Mavroukakis S, Pacenta H, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Chinnabhandar V, Kunicki M, Goksenin AY, Mackall CL, Laetsch TW, Schultz LM, Curran KJ. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Adv. 2022 Apr 12;6(7):1961-1968. PMCID: PMC9006295

59. Leahy AB, Li Y, Talano JA, Elgarten CW, Seif AE, Wang Y, Johnson B, Monos DS, Kadauke S, Olson TS, Freedman J, Wray L, Grupp SA, Bunin N. Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia. Blood Adv. 2022 Feb 22;6(4):1175-1185. PMCID: PMC8864664

60. Schultz LM, Baggott C, Prabhu S, Pacenta HL, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Rouce RH, Chinnabhandar V, Kunicki M, Barsan VV, Goksenin AY, Li Y, Mavroukakis S, Egeler E, Curran KJ, Mackall CL, Laetsch TW. Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. J Clin Oncol. 2022 Mar 20;40(9):945-955. PMCID: PMC9384925

61. Parsons SK, Rodday AM, Weidner RA, Morris E, Braniecki S, Shenoy S, Talano JA, Moore TB, Panarella A, Flower A, Milner J, Fabricatore S, Mahanti H, van de Ven C, Shi Q, Cairo MS. Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant. Bone Marrow Transplant. 2022 Apr;57(4):586-592.

62. Scheuermann A, Moskop A, Hopp A, Bone K, Drendel HM, Talano J, Harker-Murray P, Astle J. Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation. J Pediatr Hematol Oncol. 2022 Jul 01;44(5):268-270.

63. Moskop A, Pommert L, Baggott C, Prabhu S, Pacenta HL, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Margossian SP, Verneris MR, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston ML, Satwani P, Krupski C, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Guest EM, Breese EH, Schultz LM. Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia. Blood Adv. 2022 Jul 26;6(14):4251-4255. PMCID: PMC9327536

64. Pulsipher MA, Ahn KW, Bunin NJ, Lalefar N, Anderson E, Flower A, Cairo MS, Talano JA, Chaudhury S, Kitko CL, Duke JL, Monos D, Leung W, Dvorak CC, Abdel-Azim H. KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial. Blood. 2022 Dec 15;140(24):2556-2572. PMCID: PMC9918850

65. DeZern AE, Eapen M, Wu J, Talano JA, Solh M, Dávila Saldaña BJ, Karanes C, Horwitz ME, Mallhi K, Arai S, Farhadfar N, Hexner E, Westervelt P, Antin JH, Deeg HJ, Leifer E, Brodsky RA, Logan BR, Horowitz MM, Jones RJ, Pulsipher MA. Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2022 Sep;9(9):e660-e669. PMCID: PMC9444987

66. Stefanski HE, Eaton A, Baggott C, Rossoff J, Verneris MR, Prabhu S, Pacenta HL, Phillips CL, Talano JA, Moskop A, Margossian SP, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski MC, Keating AK, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium. Blood Adv. 2023 Feb 28;7(4):541-548. PMCID: PMC9979765

67. McArthur JA, Bambach B, Duncan C, Talano JA, Tamburro RT. Critical Illness Involving Children Undergoing Hematopoietic Progenitor Cell Transplantation Pediatric Critical Care: Expert Consult Premium Edition. 14 April 2011:1177-1190.

68. Schultz LM, Eaton A, Baggott C, Rossoff J, Prabhu S, Keating AK, Krupski C, Pacenta H, Philips CL, Talano JA, Moskop A, Baumeister SHC, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Kunicki M, Mavroukakis S, Egeler E, Li Y, Mackall CL, Curran KJ, Verneris MR, Laetsch TW, Stefanski H. Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia. J Clin Oncol. 2023 Jan 10;41(2):354-363. PMCID: PMC9839307

69. Chu Y, Talano JA, Baxter-Lowe LA, Verbsky JW, Morris E, Mahanti H, Ayello J, Keever-Taylor C, Johnson B, Weinberg RS, Shi Q, Moore TB, Fabricatore S, Grossman B, van de Ven C, Shenoy S, Cairo MS. Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease. Front Immunol. 2022;13:1055497. PMCID: PMC9780682

70. Escobar Vasco A, Broglie L, Talano JA, Routes J, Verbsky J, Remiker A. GATA2 deficiency detected by newborn screening for SCID: A case report. Front Pediatr. 2022;10:1031106. PMCID: PMC9886089

71. McNerney KO, Richards RM, Aguayo-Hiraldo P, Calkoen FG, Talano JA, Moskop A, Balduzzi A, Krajewski J, Dave H, Vatsayan A, Callahan C, Liu H, Li Y, Davis KL, Maude SL. SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report. J Immunother Cancer. 2023 Jan;11(1). PMCID: PMC9884906

72. Chu Y, Milner J, Lamb M, Maryamchik E, Rigot O, Ayello J, Harrison L, Shaw R, Behbehani GK, Mardis ER, Miller K, Prakruthi Rao Venkata L, Chang H, Lee D, Rosenthal E, Kadauke S, Bunin N, Talano JA, Johnson B, Wang Y, Cairo MS. Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes. J Infect Dis. 2023 Mar 28;227(6):788-799.

73. McNerney KO, Si Lim SJ, Ishikawa K, Dreyzin A, Vatsayan A, Chen JJ, Baggott C, Prabhu S, Pacenta HL, Philips C, Rossoff J, Stefanski HE, Talano JA, Moskop A, Verneris M, Myers D, Karras NA, Brown P, Bonifant CL, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Baumeister SHC, Fabrizio VA, Chinnabhandar V, Egeler E, Mavroukakis S, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL. Blood Adv. 2023 Jun 27;7(12):2758-2771. PMCID: PMC10275701

74. Geerlinks AV, Scull B, Krupski C, Fleischmann R, Pulsipher MA, Eapen M, Connelly JA, Bollard CM, Pai SY, Duncan CN, Kean LS, Baker KS, Burroughs LM, Andolina JR, Shenoy S, Roehrs P, Hanna R, Talano JA, Schultz KR, Stenger EO, Lin H, Zoref-Lorenz A, McClain KL, Jordan MB, Man TK, Allen CE, Marsh RA. Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT. Blood Adv. 2023 Jul 25;7(14):3725-3734. PMCID: PMC10368780

75. Wang H, Berger KN, Miller EL, Fu W, Broglie L, Goldman FD, Konig H, Lim SJ, Berg AS, Talano JA, Comito MA, Farag SS, Pu JJ. The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation. Ther Adv Hematol. 2023;14:20406207231170708. PMCID: PMC10161310

76. Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Lund TC, Prestidge T, Rangarajan HG, Dvorak CC, Auletta JJ, Kent M, Hashem H, Talano JA, Rotz SJ, Fraint E, Myers KC, Leung W, Sharma A, Bhatt NS, Driscoll TA, Yu LC, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA. No impact of CD34⁺ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma. Bone Marrow Transplant. 2023 Dec;58(12):1390-1393. PMCID: PMC11221560

77. Talano JA, Broglie L. Haplo ever after: haplo PTCy for children. Blood Adv. 2023 Sep 26;7(18):5637-5638. PMCID: PMC10546334

78. Vasco AE, Talano JA, Broglie L. Hemophagocytic Lymphohistiocytosis in Adolescents and Young Adults: Genetic Predisposition and Secondary Disease Medical Clinics of North America. 2023.

79. Hines M, Bhatt N, Talano JAM. Diagnosis, Treatment, and Management of Hemophagocytic Lymphohistiocytosis in the Critical Care Unit Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide. 1 January 2019:159-182.

80. Duncan CN, Talano JAM, McArthur JA. Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient: An Evidence-Based Guide. 1 January 2019:1-417.

81. Barsan V, Li Y, Prabhu S, Baggott C, Nguyen K, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano JA, Moskop A, Baumeister S, Verneris MR, Myers GD, Karras NA, Cooper S, Qayed M, Hermiston M, Satwani P, Krupski C, Keating A, Fabrizio V, Chinnabhandar V, Kunicki M, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns eClinicalMedicine. November 2023;65.

82. Vasco AE, Talano JA, Broglie L. Hemophagocytic Lymphohistiocytosis in Adolescents and Young Adults: Genetic Predisposition and Secondary Disease. Med Clin North Am. 2024 Jan;108(1):189-200.

83. Eylon M, Prabhu S, John S, King MJM, Bhatt D, Curran KJ, Erickson C, Karras NA, Phillips CL, Satwani P, Hermiston M, Southworth E, Baumeister SHC, Talano JA, MacMillan ML, Rossoff J, Bonifant CL, Myers GD, Rouce RH, Toner K, Driscoll TA, Katsanis E, Salzberg DB, Schiff D, De Oliveira SN, Capitini CM, Pacenta HL, Pfeiffer T, Shah NC, Huynh V, Skiles JL, Fraint E, McNerney KO, Quigg TC, Krueger J, Ligon JA, Fabrizio VA, Baggott C, Laetsch TW, Schultz LM. Mediport use as an acceptable standard for CAR T cell infusion. Front Immunol. 2023;14:1239132. PMCID: PMC10642031

84. Barsan V, Li Y, Prabhu S, Baggott C, Nguyen K, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano JA, Moskop A, Baumeister S, Verneris MR, Myers GD, Karras NA, Cooper S, Qayed M, Hermiston M, Satwani P, Krupski C, Keating A, Fabrizio V, Chinnabhandar V, Kunicki M, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns. EClinicalMedicine. 2023 Nov;65:102268. PMCID: PMC10632672

85. Böhm S, Wustrau K, Pachlopnik Schmid J, Prader S, Ahlmann M, Yacobovich J, Beier R, Speckmann C, Behnisch W, Ifversen M, Jordan M, Marsh R, Naumann-Bartsch N, Mauz-Körholz C, Hönig M, Schulz A, Malinowska I, Hines M, Nichols KE, Gil-Herrera J, Talano JA, Crooks B, Formankova R, Jorch N, Bakhtiar S, Kühnle I, Streiter M, Nathrath M, Russo A, Dürken M, Lang P, Lindemans C, Henter JI, Lehmberg K, Ehl S. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation. Blood. 2024 Mar 07;143(10):872-881.

86. Braniecki S, Vichinsky E, Walters MC, Shenoy S, Shi Q, Moore TB, Talano JA, Parsons SK, Flower A, Panarella A, Fabricatore S, Morris E, Mahanti H, Milner J, McKinstry RC, Duncan CN, van de Ven C, Cairo MS. Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial. Front Neurol. 2024;15:1263373. PMCID: PMC11151850

87. Bender JD, Damodharan S, Capitini CM, Moskop A, Toner K, Vatsayan A, Talano JA, Baggott C, Schiff D, Katsanis E, Modi AJ, Quigg TC, Raikar SS, Schultz LM, Pommert L. Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Adv. 2024 Aug 13;8(15):4164-4168. PMCID: PMC11334869

88. Dvorak CC, Long-Boyle JR, Holbrook-Brown L, Abdel-Azim H, Bertaina A, Vatsayan A, Talano JA, Bunin N, Anderson E, Flower A, Lalefar N, Higham CS, Kapoor N, Klein O, Odinakachukwu MC, Cho S, Jacobsohn DA, Collier W, Pulsipher MA. Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancy. Blood Adv. 2024 Dec 10;8(23):6003-6014. PMCID: PMC11629297

89. Moskop A, Talano J. Pancytopenia/Aplastic Anemia/Bone Marrow Failure Nelson Pediatric Symptom-Based Diagnosis: Common Diseases and their Mimics. 1 January 2022:927-941.e2.

90. Dvorak CC, Long-Boyle JR, Holbrook-Brown L, Abdel-Azim H, Bertaina A, Vatsayan A, Talano JA, Bunin NJ, Anderson EJ, Flower A, Lalefar NR, Higham CS, Kapoor N, Klein O, Odinakachukwu MC, Cho S, Jacobsohn DA, Collier W, Pulsipher MA. Effect of Rabbit ATG PK on Outcomes after TCR-αβ/CD19-depleted Pediatric Haploidentical HCT for Hematologic Malignancy. Blood Adv. 2024 Jul 23:bloodadvances.2024012670. doi: 10.1182/bloodadvances.2024012670. Epub ahead of print. PMID: 39042892.

91. Bender JD, Damodharan S, Capitini CM, Moskop A, Toner K, Vatsayan A, Talano JA, Baggott C, Schiff D, Katsanis E, Modi AJ, Quigg TC, Raikar SS, Schultz LM, Pommert L. Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Adv. 2024 Aug 13;8(15):4164-4168. doi: 10.1182/bloodadvances.2024012928. PMID: 38916857; PMCID: PMC11334869.

92. Braniecki S, Vichinsky E, Walters MC, Shenoy S, Shi Q, Moore TB, Talano JA, Parsons SK, Flower A, Panarella A, Fabricatore S, Morris E, Mahanti H, Milner J, McKinstry RC, Duncan CN, van de Ven C, Cairo MS. Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trial. Front Neurol. 2024 May 22;15:1263373. doi: 10.3389/fneur.2024.1263373. PMID: 38841694; PMCID: PMC11151850

1. Talano JM, Margolis DA. Recent Molecular and Cellular Advances. In: Pediatric Bone Marrow Transplantation. Pediatric Clinics of North America. Vol 53. 2006:685-698.

2. Talano JM, Casper J, Margolis D. Hematopoietic Cell Transplant for Childhood Acute Myeloid Leukemia. In: Appelbaum F, Forman S, Negrin R, Blume K, eds. Thomas' Hematopoietic Cell Transplantation, 4th edition. Massachusetts: Blackwell Publishing, 2009.

3. McArthur J, Bambach B, Duncan C, Talano J, Tamburro B. Critical Illness Involving Children Undergoing Hematopoietic Stem Cell Transplant. In: Fuhrman and Zimmerman, eds. Pediatric Critical Care, 4th edition. New York: Elsevier Publishing, 2011.

4. Erker C, Harker-Murray P, Talano J. Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. Accepted for publication. Pediatric Clinics of North America.

5. McArthur J, Bambach B, Duncan C, Talano J, Tamburro B. Critical Illness Involving Children Undergoing Hematopoietic Stem Cell Transplant. In: Fuhrman and Zimmerman, eds. Pediatric Critical Care, 5th edition. New York: Elsevier Publishing, 2017

6. Dobrozi S, Talano J, Camitta B. Hematopoetic Cell Transplants for Children with Acute Lymphoblastic Leukemia. In Hillard Lazarus, Hematopoetic Cell Transplants Concepts, Controversies and Future Directions, Cambridge University Press 2017

7. Duncan C, Talano J, McArthur J. Editors: Critical Care of the Pediatric Immunocompromised Hematology Oncology Patient. An Evidence Based Guide. Springer International Publishing 2019

8. Hines M, Bhatt N, Talano J. Diagnosis, Treatment and Management of Hemophagocytic Lymphohistiocytosis in the Critical Care Unit. Critical Care of the Pediatric Immunocompromised Hematology Oncology Patient. Springer International Publishing 2019

1. Talano, J.; Katz, B. Z. "Outcome of Fever of Unknown Origin in Children." Presented at the Infectious Diseases Society of America 36th Annual Meeting, November, 1998.

2. Talano, J.; Johnson, S.; Gottschall, J.L.; Curtis, B.R.; Scott, J.P. "IgA- Mediated Autoimmune Hemolytic Anemia Detected by Flow Cytometry Responsive to Cyclosporin A Therapy." Presented at the Pediatric Academic Societies Meeting, May, 2000.

3. Talano, J.; Gottschall, J.L.; Johnson, S.T.; Pugh, T.M.; Hillery, C.A.; Scott, J.P. "Partial Phenotype Matching (Rh, Kell) Reduces Alloimmunization in Children with Sickle Cell Disease." Presented at the American Society of Pediatric Hematology/Oncology 13th Annual Meeting, September, 2000.

4. Talano, J.; Hillery, C.A.; Gottschall, J.L.; Baylerian, D.M.; Scott, J.P. "Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease." Presented at the American Society of Pediatric Hematology/ Oncology 14th Annual Meeting, April, 2001.Presented at the Annual Sickle Cell Meeting, April 2001.

5. Talano, J.M.; Johnson, S.T.; Friedman, K.D.; Ilstrup, S.J.; Treisman, J.S.; Curtis, B.R.; Scott, J. P.; Gottschall, J.L. " Serologic Characteristics of Three Cases of IgA Mediated Autoimmune Hemolytic Anemia (AIHA) Confirmed by Flow Cytometry." Presented at the American Society of Hematology Annual Meeting, December 2002.

6. Talano, J.M.; Margolis, D.A.; Camitta, B.M.; Keever-Taylor, C.A.; Murray, K.J.; Eapen, M.; Pierce, K.L.; Casper, J.T. "Outcome of Unrelated and Haploidentical Bone Marrow Transplants in Children with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)." Presented at the American Society of Hematology Annual Meeting, December 2002.

7. Talano, J.M.; Keever-Taylor, C.A., Eapen, M., Casper, J.T., Margolis, D.A. "Haploidentical Family Donor Transplants in Children Using High Doses of Positively Selected CD34+ Cells with Low CD3+ Cells: An Initial Report of the Milwaukee Experience." Presented at the American Society of Hematology Annual Meeting, December 2003.

8. Talano, J.M.; Camitta, B.; Keever-Taylor, C.A.; Anderson, L.A.; Wallach, C.; Casper; J. "Long Term Outcomes of Unrelated Donor Bone Marrow Transplantation in Children with Severe Aplastic Anemia: An Update of the Milwaukee Experience. Presented at the National Marrow Donor Program Meeting, November 2006 awarded Best Abstract. Presented at the American Society of Hematology Annual Meeting, December 2006.

9. Prasad V.K., Lucas K.G., Kleiner G.I., Talano J.M., Jacobson D., Szabolcs P., Monroy R., Kurtzberg J. "Use of Mesenchymal Stem Cells to Treat Pediatric Patients with Severe (Grade III-IV) acute Graft versus Host Disease Refractory to Steroid and Other Agents on a Compassionate Use Basis." Presented at the American Society of Hematology Annual Meeting, December 2007

10. McArthur J, Mikalov T, Talano J. Relationship between Acetaminophen Dosage and Development of Organ Dysfunction during Pediatric Hematopoetic Stem Cell Transplant. Presented at the American Society for Blood and Marrow Transplant, February 2009

11. Talano, J, Biank, V, Casper, J, Margolis,D, Stephens. M. Secondary Hemophagocytic Lymphohistiocytosis in Adolescent Patients with Crohn's Disease.Presented at the International Histocyte Society meeting, Bilbao Spain September 2009

12. Talano, J, Brown, J Eastwood, D, McArthur, J, Casper,J, Margolis, D. Analysis of the Incidence and Characteristics of Venoocclusive Disease (VOD) of the Liver in Pediatric Hematopoietic Progenitor Cell Transplant (HPCT) Patients with Heparin alone vs. Heparin and Ursodiol Prophylaxis at the Medical College of Wisconsin. American Society of Bone Marrow Transplant Meeting 2010. American Society of Pediatric Hematology Oncology 2010

13. Szabolics, P, Visani, G, Locatelli,F, Kleiner, G, Talano, J, Nemecek, E, Kurtzberg, J. Treatment of steroid-refractory acute GVHD with mesenchymal stem cells improves outcomes in pediatric patients; Results of the pediatric subset in a phase III randomized, placebo-controlled study. Presented at the American Society of Bone Marrow Transplant Meeting 2010

14. Mulberry, M, Casper, J, Margolis, D, Talano, J. A Case Report of a Pediatric Patient with T Cell Acute Lymphoblastic Leukemia (ALL) CR2 with Neurologic Deficits Secondary to Enterovirus Encephalitis with Substantial Recovery of Function Post Umbilical Cord Transplantation. Presented at the 8th Annual International Umbilical Cord Blood Transplantation Symposium 2010.

15. Rangarajan, H, Grochowski, D, Mulberry, M. Talano, J. Successful Treatment of Recurrent CNS Disease in Familial HLH post Bone Marrow Transplant: Frequent Monitoring and Preemptive Therapy has Shown to be An Effective Treatment Strategy. Presented at the International Histiocyte Meeting. Boston, MA. 2010

16. Angela Ricci, Mark Geyer, Lauren Harrison, Dierdre Duffy, Monica Bhatia, James Garvin, Diane George, Prakash Satwani, Alexa Cheerva, Julie Talano, M. Fevzi Ozkaynak, Theodore Moore, Joseph Schwartz, LeeAnn Baxter-Lowe, Mitchell S. Cairo. Pediatrics, Columbia University, New York, NY; Pediatrics, University of Louisville, Louisville, KY; Pediatrics, Medical College of Wisconsin, Milwaukee, WI; Pediatrics, New York Medical College, Valhalla, NY; Pediatrics, Univeristy of California Los Angeles, Los Angeles, CA; Pathology and Cell Biology, Columbia University, New York, NY; Surgery, University of California San Francisco, San Francisco, CA; Medicine, Columbia University, New York, NY. Preliminary Results of Phase I/II Study of Clofarabine (CLO) in Combination with Cytarabine (ARA-C) and Total Body Irradiation (TBI) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) in Children, Adolescents and Young Adults (CAYA) with Poor-Risk Acute Leukemia Presented at American Society of Hematology Oral Presentation 2010, Pediatric Academic Society Meeting, Denver, CO 2011, ASBMT 2011

17. Radhakrishnan,K.Talano,J.Taylor,C.Bhatia,M.Shenoy,S.Walters,M.Parsons,S.Morris,E.Baxter-Lowe,L.A.Cairo,M. Familial Haploidentical (FHI) T-cell Depleted(TCD)Transplantation in High-Risk Sickle Cell Disease (SCD). American Society of Blood and Marrow Transplant Annual Meeting 2011

18. Rangarajan,H. Cogbill,C. Grochowski,D. Georghe, G. Talano, J. Systemic EBV-Positive T cell Lymphoproliferative Disease of Childhood: A Case Report. American Society Pediatric Hematology Oncology 2012

19. Talano, J., Keever Taylor, C., Shenoy, S., Walters, M., Radhakrishnan, K., Parsons, S., Morris, E., Baxter-Lowe, L.A., Moore, T., Cairo, M. Familial haploidentical (FHI) T-cell depleted (TCD) with Tcell addback stem cell transplantation in children with high-risk sickle cell disease (SCD) (IND14359) (RO1FD004090-01A1). Presented, American Society of Pediatric Hematology/Oncology 26th Annual Meeting. Pediatric Blood & Cancer 60 (S2) 2013;S99 #915.

20. Burroughs, L., Nemecek, E., Torgerson, T., Gutherie, K., Talano, J., Domm, J., Shimamura, A., Carpenter, P., Skoda-Smith, S.,Englund, J., Baker, KS., Storb, R., Woolfrey, A. Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study. Presented, American Society of Blood and Marrow Transplant Annual Meeting, Biology of Blood and Marrow Transplantation Vol. 19, Issue 2, Supplement, Page S158. 2013

21. Chen, N., Radhakrishnan, K., Krajewski, J., Ricci, A.M., Geyer, M., Harrison, L., Ozkaynak, M.F., Cheerva, A.C., Talano, J., Moore, T., Gillio, A., Baxter-Lowe, L-A., Cairo, M. Low day 100 transplant related mortality and relapse rate following clofarabine in combination with cytarabine, total body irradiation and allogeneic stem cell transplantation in children, adolescents and young adults with poor-risk acute leukaemia. Presented, American Society of Pediatric Hematology/Oncology 26th Annual Meeting. Pediatric Blood & Cancer 60 (S2) 2013;S95 #902. Presented, European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 2013; 48(2):S280 #P870. Presented, Eastern Society for Pediatric Research, 2013. 2013 ESPR Annual Meeting: 59 #154. Presented, 2013 BMT Tandem Meetings. Biology of Blood and Marrow Transplantation 2013; 19(2) Supp 2:S251 #278.

22. Bajwa, R., McArthur, J., Talano, J., Fitzgerald, J., Duncan, C., Margossian, S., Yates, A., Hall, M., Cunnigham, S., Spear, D., Luther, K., Tamburro, R. Assessment of Brain Natriuretic Peptide in Patients Undergoing Hematopoietic Stem Cell Transplantation. Presented at 2013 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation Vol. 19, Issue 2, Supplement, Pages S257-S258

23. . Rangarajan, H., Punzalan, R., Talano, J., The Safety and Tolerability of the Novel Therakos Cellex Machine for Extracorporeal Photopheresis in the Treatment of GVHD in Children. . Presented at 2013 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation Vol. 19, Issue 2, Supplement, Page S255

24. Kurtzberg, J., Prockop, S., Teira, P., Bittencourt, H., Lewis, V., Chan, K., Horn, B., Yu, L., Talano, J. et al. Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients Biology of Blood and Marrow Transplant, Vol. 20, Issue 2, p229–235

25. Talano, J., Keever-Taylor, C., Walters, M., Shenoy, S., Moore, T., Parsons, S., Abikoff, C., Dozor, A., Friedman, D., Chitti, R., Shi, Q., Grossman, B., Weinberg, R., Morris, E., Brand, P., Mangan, D., Foley, S., Militano, O., Ayello, J., Semidei-Pomales, M., Baxter-Lowe, L., Cairo, M. Familial Haploidentical (FHI) T-Cell Depleted (TCD) with T-Cell Addback Stem Cell Transplantation for Patients with High-Risk Sickle Cell Disease (SCD) (IND 14359) Presented at 2014 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation Vol. 20, Issue 2, Supplement, Pages S135-S13

26. Satwani, P., Jin,Z., Bhatia, M., Garvin, J., George, D., Chaudhury, S., Talano, J., Sosna, J., Morris, E., Harrison, L., Martin, P., Peterson, M., Kurtzberg, J., Cairo, M. Sequential Myeloablative Autologous Stem Cell Transplantation and Reduced Intensity Allogeneic Stem Cell Transplantation in Children, Adolescents and Young Adults with Poor Risk Refractory or Recurrent Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL) Oral Presentation at 2014 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation Vol. 20, Issue 2, Supplement, Page S85

27. . Chen, N., Radhakrishnan, K., Krajewski, J., Ricci, A., Geyer, M., Harrison, L., Ozkaynak, M., Cheerva, A., Talano, J., Moore, T., Gillio, A., Walters, M., Baxter-Lowe, L., Cairo, M. Low Day 100 Transplant-Related Mortality and Relapse Rate Following Clofarabine in Combination with Cytarabine, Total Body Irradiation and Allogenic Stem Cell Transplantaiton in Children, Adolescents and Young Adults with Poor-Risk Acute Leukemia. Oral Presentation at 2014 American Society of Blood and Marrow Transplant Meeting. Biology of Blood and Marrow Transplantation Vol. 20, Issue 2, Supplement, Pages S79-S80

28. Talano, J. M., J. Brown, J. T. Casper, M. Mulberry, D. Eastwood, K. W. Ahn and D. A. Margolis "Analysis Of The Incidence And Characteristics Of Venoocclusive Disease (VOD) Of The Liver In Pediatric Hematopoietic Progenitor Cell Transplant (HPCT) Patients With Heparin Alone Vs. Heparin And Ursodiol Prophylaxis At The Medical College Of Wisconsin." Biology of Blood and Marrow Transplantation 16(2): S248.

29. Talano, J., et al. Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation Utilizing CD34 Enrichment and T Cell Addback in Children, Adolescents & Adults with High-Risk Sickle Cell Disease. Rapid Engraftment, Immune Reconstitution, Low Incidence of GVHD, and Sustained Donor Chimerism. J Talano ASPHO Annual Meeting Oral presentation May 2016 Minneapolis Pediatric Blood and Cancer Volume 63, Issue S1, June 2016

30. Nemecek, E., Adams, A., Shaw, B., Kiefer, Deidre M., Le-Rademacher, J., Levine, J.,Yanik, G.,.Leung, W.,Talano, J., et al. Phase II Study of Treosulfan/Fludarabine/ Low Dose Total Body Irradiation As a Preparative Regimen for Children with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Allogeneic Hematopoietic Cell Transplantation. Oral Presentation ASBMT Honolulu HI 2016 Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S99

31. Chu, Y., Brand, P., Morris, E., Lee, F., Talano, J., Shenoy, S., Moore, T., Keever-Taylor, C., Weinberg, R., Grossman, B., Cairo, M. Natural Killer Cell Reconstitution Following Familial Haploidentical (FHI) CD34 Enriched Stem Cell Transplantation with T-Cell Add Back in Patients with High Risk Sickle Cell Disease (SCD) (IND 14359) Poster ASBMT Honululu HI 2016. Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S151–S152

32. Keever-Taylor, C., Weinberg, R., Grossman, B., Shenoy, S., Talano, J., Moore,T., et el. Collection and Processing Outcomes of G-CSF Mobilized Peripheral Blood Stem Cells (PBSC) Collected from Parental Haploidentical Stem Cell Sickle Cell Trait Donors of Patients Undergoing CD34 Enriched Transplantation for High-Risk Sickle Cell Disease Poster ASBMT Honululu HI 2016 Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S383–S384

33. Seif, A., Li, Y., Aplenc, R., Barrett, R., Casper, J., Freedman, J., Grupp, S., Margolis, D., et al. CD3/CD19 Depletion with Targeted T Cell Add-Back Results in Stable Engraftment and Minimal GVHD in Pediatric Patients with Bone Marrow Failure Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplantation Oral presentation ASBMT Honululu HI 2016 Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S62–S63

34. Duncan, C., Brazauskas, R., Huang, J., Shaw, B., Majhail, N., Savani, B., Flowers, M., Battiwalla, M., Talano, J. et al. Late Cardiovascular Morbidity Following Pediatric Allogeneic Hematopoietic Cell Transplantation Oral Presentation ASBMT Honululu HI 2016 Biology of Blood and Marrow Transplant, Vol. 22, Issue 3, S60

35. Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation (AlloSCT) Utilizing CD34 Enrichment and PB MNC Addback in Children and Adolescents with High Risk Sickle Cell Disease (SCD): Rapid Engraftment, Immune Cell Reconstitution, and Sustained Donor Chimerism (IND 14359) Poster American Society of Hematology Annual meeting San Diego, CA 2016

36. Parsons SK, Rodday AM, Weidner RA, Morris E, Moore TB, Shenoy S, Talano J-A, Minzer S, Fabricatore S, Braniecki S, Cairo MS. Trajectories of Children’s Health-Related Quality of Life after Myeloimmuno Ablative Conditioning Familial Haploidentical T-Cell Depleted with T-Cell Addback Stem Cell Transplantation for Poor Risk SCD. Poster Presentation. American Society of Blood and Marrow Transplant Annual Meeting Orlando, FL 2017 Biology of Blood and Marrow Transplantation , Volume 23 , Issue 3 , S227 - S228

37. Newsom S, Bock A, LeVeque M, Talano J, High Dose Corticosteroid Therapy for Treatment of Late Pulmonary Disease Post-HSCT in Children and Adolescents. American Society of Pediatric Hematology/Pediatric Blood and Marrow Transplant Meeting, Montreal Canada 2017 Poster Presentation Pediatric Blood and Cancer, Volume 64, S 98

38. Broglie L, Talano J, Moore T, Shenoy S, Mahanti S, Morris E, Horowitz T, Fabricatore S, Abikoff C, Dozor A, Cairo M. Stabilization of Pulmonary Function in Pediatric and Young Adult Sickle Cell Disease (SCD) Recipients Undergoing Myelo-immunesuppressive (MIC) and Familial Haploidentical (FHI) Transplantation Enriched CD34 Selection and T-cell add back. American Society of Pediatric Hematology/Pediatric Blood and Marrow Transplant Meeting, Montreal Canada 2017 Poster Presentation Pediatric Blood and Cancer, Volume 64, S99

39. Braniecki S, Talano J, Moore T, Weinberg R,. Keever-Taylor C, Grossman B, Baxter-Lowe L, Parsons S, Morris E, Fabricatore S, Neurocogntive and Neurological Outcomes in Children Adolescents and Young Adults with High Risk Sickle Cell Disease (SCD) who have Undergone Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation Utilizing CD34 Enrichment and T Cell Addback Following Myeloimmunoablative Conditioning (MIC) American Society of Pediatric Hematology/Pediatric Blood and Marrow Transplant Meeting, Montreal Canada 2017 Poster Presentation Pediatric Blood and Cancer, Volume 64, S100

40. Broglie L, Pommert L, Rao S, Thakar M, Phelan R, Margolis D ,Talano J. Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis. Histiocyte Annual Meeting Singapore 2017

41. Yara Perez, Liana Klejmont, Harshini Mahanti, Jessica Hochberg, Allyson Flower, Qiuhu Shi, Theodore B. Moore, Julie-An M. Talano et al. Elevated Pre-HSCT Ferritin is Not Associated with Increased Risk of Acute Graft Versus Host Disease in Patients with High Risk Sickle Cell Disease Undergoing Haploidentical T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) ASBMT February 2018

42. Allyson Flower, Julie-An M. Talano, Theodore B. Moore, Shalini Shenoy, Larisa Broglie, Harshini Mahanti, Erin Morris, Sandra Fabricatore et al. Stable Pulmonary Function after Myeloimmunosupressive Conditioning (MIC) and Familial Haploidentical (FHI) Transplantation Utilizing CD34+ Enrichment and PBMC (CD3) Add Back in Children and Young Adults with High Risk (HR) Sickle Cell Disease (SCD) ASBMT February 2018

43. Cairo, M., Parsons, S. K., Braniecki, S., Talano, J., Moore, T. B., Shi, Q., Keever-Taylor, C. A., Weinberg, R. S., Grossman, B. J., Dozor, A. J., Friedman, D., McKinstry, R. C., Verbsky, J., Moorthy, C. R., Weidner, R. A., Rodday, A. M., Ayello, J., Semidei-Pomales, M., Flower, A. M., Chu, Y., Morris, E., Mahanti, H., Fabricatore, S., Militano, O., Klejmont, L., van de Ven, C., Baxter-Lowe, L. A., Vichinsky, E., Walters, M. C., & Shenoy, S. (2018). Significantly Improved Long Term Health Related Quality of Life (HRQL) and Neurocognition Following Familial Haploidentical Stem Cell Transplantation (HISCT) Utilizing CD34 Enrichment and Mononuclear (CD3) Addback in High Risk Patients with Sickle Cell Disease (SCD). Blood, 132(Suppl 1), 162. Oral Presentation ASH 2018 https://doi.org/10.1182/blood-2018-162.

44. Yaya Chu, Julie-An Talano, Lee Ann Baxter-Lowe, Carolyn A. Keever-Taylor, Erin Morris, Harshini Mahanti, Janet Ayello, Rona Singer Weinberg, Qiuhu Shi, Theodore B. Moore, Sandra Fabricatore, Brenda J. Grossman, Carmella van de Ven, Shalini Shenoy, Mitchell S Cairo; Sustained Donor Chimerism and Rapid Immune Cell Reconstitution Following Familial Haploidentical (FHI) CD34 Enriched Stem Cell Transplantation with Pbmnc Addback in Patients with High Risk Sickle Cell Disease (SCD) (IND 14359). Blood 2019; 134 (Supplement_1): 1990. doi: https://doi.org/10.1182/blood-2019-126757

45. Hisham Abdel-Azim, Christopher C. Dvorak, Nancy Bunin, Mark C. Walters, Julie-An Talano, Eric Jon Anderson, Jemily Malvar, May Al Jassani, Sonali Chaudhury, Mitchell S Cairo, Carrie Kitko, Allison P. Jacob, Dimitri S. Monos, Leung Wing, Michael A. Pulsipher; Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach or Graft Alpha/Beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL). Blood 2019; 134 (Supplement_1): 4624. doi: https://doi.org/10.1182/blood-2019-131706

46. Allyson Flower, Janet Ayello, Lauren Harrison, Erin Morris, Meghan Sturhahn, Elena Maryamchik, Yongping Wang, Lynn O’Donnell, Rolla Abu-Arja, Dean Lee, Julie-An M. Talano, Bryon D Johnson, Mitchell S. Cairo. The Safety and Efficacy of Targeted Virus Specific Cytotoxic T-Lymphocytes (VST) Manufactured By the IFN-g Cytokine Capture System (CCS) for the Treatment of Refractory Adenovirus (ADV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) and BK Virus (BKV) in Children, Adolescents and Young Adults (CAYA) after Allogenic Hematopoietic Stem Cell Transplantation (Allo-HSCT), Solid Organ Transplantation (SOT), or with Primary Immunodeficiency (PID) (IND# 17449). Oral Presentation TCT Orlando FL 2020

47. Boyer M, Chaudhury S, Davis K, Driscoll T, Grupp S, Hermiston M, John S, Keating A, Kovacs C, Myers GD, Phillips C, Pulsipher M, Talano JA, Kari G, Willert J. Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia: HESTER Phase II Study. Poster Session. Society of Hematologic Oncology (SOHO) Annual Meeting. 09/2021